EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Change in Receivables (2011 - 2026)

EyePoint (EYPT) posted Change in Receivables of $5.0 million for Q1 2026, down 54.05% sequentially from $10.8 million in Q4 2025, and up 244.52% YoY from $1.4 million in Q1 2025.

Analysis

EyePoint (EYPT) Change in Receivables (2011 - 2026) Analysis & Trends

EyePoint has reported Change in Receivables for 16 years, with the latest figure at $5.0 million in Q1 2026.

  • Quarterly Change in Receivables rose 244.52% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (up 355.9% YoY) and the FY2025 annual result came in at $10.7 million, up 4271.72% from the prior year.
  • Change in Receivables fell to $5.0 million in Q1 2026 per EYPT's latest filing, from $10.8 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $10.8 million in Q4 2025 and troughed at -$10.7 million in Q3 2023.
  • A 5-year average of $240882.4 and a median of $269000.0 in 2023 frame the typical range for Change in Receivables.
  • The sharpest annual moves came in 2023 and 2025: Change in Receivables slumped 2820.65% in 2023, then jumped 678.69% in 2025.
  • Over 5 years, Change in Receivables stood at -$6.3 million in 2022, then soared by 104.28% to $269000.0 in 2023, then slumped by 792.57% to -$1.9 million in 2024, then surged by 678.69% to $10.8 million in 2025, then tumbled by 54.05% to $5.0 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods registered $5.0 million, $10.8 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -53.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 117.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 31.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 37.16 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 -19.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.25 Mn
Mar 31, 2026 4.95 Mn
Dec 31, 2025 10.78 Mn
Sep 30, 2025 3.13 Mn
Jun 30, 2025 180,000.00
Mar 31, 2025 -3.43 Mn
Dec 31, 2024 -1.86 Mn
Sep 30, 2024 939,000.00
Jun 30, 2024 -3.09 Mn
Mar 31, 2024 4.26 Mn
Dec 31, 2023 269,000.00
Sep 30, 2023 -10.75 Mn
Jun 30, 2023 979,000.00
Mar 31, 2023 -4.93 Mn
Dec 31, 2022 -6.28 Mn
Sep 30, 2022 -368,000.00
Jun 30, 2022 6.37 Mn
Mar 31, 2022 2.94 Mn
Dec 31, 2021 5.98 Mn
Sep 30, 2021 -1.32 Mn